Cleveland BioLabs (CBLI)

Add to Watchlists
Create an Alert
0.6331 +0.03  +5.52% NASDAQ Apr 16, 5:00PM BATS Real time Currency in USD
View Full Chart
CBLI Price Chart
View All Events

CBLI Events

Date Type Description
Jun 14 Misc AGM Event for Cleveland BioLabs Inc
View All Performance Charts

CBLI Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Cleveland BioLabs is down 66.50% over the last year vs S&P 500 Total Return up 22.52%, Athersys up 27.80%, and Vertex Pharmaceuticals up 19.09%.

Get Quote for

Pro Strategies Featuring CBLI

Did Cleveland BioLabs make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.

CBLI Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: New York
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Current Fiscal Year End: December 31, 2014
  • NAICS: Research and Development in Biotechnology
  • NAICS Code: 541711
  • NAICS Industry: Scientific Research and Development Services
  • NAICS Industry Code: 5417
  • NAICS Sector: Professional, Scientific, and Technical Services
  • NAICS Sector Code: 54

Cleveland BioLabs, Inc., is adrug development company seeking to develop first-in-class pharmaceuticals designed to address diseases with significant unmet medical need.

Recent Quotes

Symbol Price Chg Chg % Market Cap
CBLI 0.6331 +0.03 +5.52% 28.60M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.